«12345»Seite
5 Artikel mit Literatur, Seite 4 von 5

MEDIZIN

Serie: Behandlung von nicht und mäßig metastasierten Hodentumoren

Treatment of non-metastatic and moderate metastatic testicular cancer

Dtsch Arztebl 2005; 102(46): A-3191 / B-2697 / C-2524

Krege, Susanne; Albers, Peter; Schmidberger, Heinz

1. Sobin LH, Wittekind Ch, Hrsg.: UICC: TNM classification of malignant tumours, 6th edition. New York: Wiley-Liss 2002.
2. Schmoll HJ, Souchon R, Krege S et al.: European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG). Ann Oncol 2004; 15: 1377–99. MEDLINE
3. Warde P, Specht L, Horwich A et al.: Prognostic factors for relapse in stage I seminoma managed by surveillance. J Clin Oncol 2002; 20: 4448–52. MEDLINE
4. Aparicio J, Garcia Del Muro X, Maroto P et al.: Multicenter study evaluating a dual policy of postorchiectomy surveillance and selective adjuvant single-agent carboplatin for patients with clinical stage I seminoma. Ann Oncol 2003; 14: 867–72. MEDLINE
5. Classen J, Schmidberger H, Meisner Ch et al.: Paraaortic irradiation for stage I testicular seminoma: Results of a prospective study in 675 patients. Br J Cancer 2004; 90: 2305–11. MEDLINE
6. Jones WG, Fossa SD, Mead GM et al.: A randomised trial of two radiotherapy schedules in the adjuvant treatment of stage I seminoma (MRC TE 18). Eur J Cancer 2001; 37 (Suppl. 6): 157, Abstract 572.
7. DeSantis M, Albrecht W, Höltl W, Pont J: Impact of cytotoxic treatment on long-term fertility in patients with germ cell cancer. Int J Cancer 1999; 83: 864–5. MEDLINE
8. Dieckmann KM, Bruggeboes B, Pichlmeier U et al.: Adjuvant treatment of clinical stage I seminoma: is a single course of carboplatin sufficient? Urology 2000; 55: 102–6. MEDLINE
9. Oliver RT, Mason M, von der Maase H et al. on behalf of the MRC Testis Tumour Group and the EORTC GU Group: A randomised comparison of single-agent carboplatin with radiotherapy in the adjuvant treatment of stage I seminoma of the testis, following orchidectomy: MRC TE 19/ EORTC 30982. Proc Am Soc Clin Oncol 2004; 23: 385, Abstract 4517.
10. Classen J, Schmidberger H, Meisner C et al.: Radiotherapy for stage IIA/B testicular seminoma: final report of a prospective multicenter clinical trial. J Clin Oncol 2003; 21: 1101–6. MEDLINE
11. Albers P, Weissbach L, Krege S et al.: Prediction of necrosis after chemotherapy of advanced germ cell tumors: results of a prospective multicenter trial of the German Testicular Cancer Study Group. J Urol 2004; 171: 1835–8. MEDLINE
12. De Santis M, Becherer A, Bokemeyer C et al.: 2–18 fluoro-deoxy-D-glucose positron emission tomography reliable predictor for viable tumor in postchemotherapy seminoma : an update of the prospective multicentric SEMPET trial. J Clin Oncol 2004; 22: 1034–9. MEDLINE
13. Ondrus D, Matoska J, Belan V et al.: Prognostic factors in clinical stage I nonseminomatous germ cell testicular tumors: rationale for different risk-adapted treatment. Eur Urol 1998; 33: 562–6. MEDLINE
14. Laguna MP, Klepp O, Horwich A et al.: Guidelines on testicular cancer, European Association of Urology, March 2004, www.uroweb.org.
15. Albers P, Siener R, Kliesch S et al.: Risk factors for relapse in clinical stage I nonseminomatous testicular germ cell tumors: results of the German Testicular Cancer Study Group trial. J Clin Oncol 2003; 21: 1505–12. MEDLINE
16. Pont J, Albrecht W, Postner G et al.: Adjuvant chemotherapy for high-risk clinical stage I nonseminomatous testicular germ cell cancer : long-term results of a prospective trial. J Clin Oncol 1996; 14: 441–8. MEDLINE
17. Bohlen D, Burkhard FC, Mills R et al.: Fertility and sexual function following orchiectomy and two cycles of chemotherapy for stage I high risk nonseminomatous germ cell cancer. J Urol 2001; 165: 441–4. MEDLINE
18. Heidenreich H, Albers P, Hartmann M et al.: Complications of primary nerv-sparing retroperitoneal lymph node dissection on clinical stage I nonseminomatous germ cell tumors of the testis. German Testicular Cancer Study Group. J Urol 2003; 169: 1710–4. MEDLINE
19. International Germ Cell Cancer Collaborative Group (IGCCCG). The International Germ Cell Consensus classification: a prognostic factor based staging system for metastatic germ cell cancer. J Clin Oncol 1997; 15: 594–603. MEDLINE
20. Weissbach L, Bussar-Maatz R, Flechtner H et al.: RPLND or primary chemotherapy in clinical stage IIA/B nonseminomatous germ cell tumors? Results of a prospective multicenter trial including quality of life assessment. Eur Urol 2000; 37: 582–94. MEDLINE
«12345»Seite
5 Artikel mit Literatur, Seite 4 von 5

Login

E-Mail

Passwort


Passwort vergessen?

Registrieren

Eingeloggt als

Suchen in